Acadian Asset Management’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.3M | Hold |
|
|||||
|
2025
Q1 | $2.74M | Sell |
|
|||||
|
2024
Q4 | $3.12M | Hold |
|
|||||
|
2024
Q3 | $3.12M | Sell |
|
|||||
|
2024
Q2 | $3.09M | Sell |
|
|||||
|
2024
Q1 | $3.89M | Hold |
|
|||||
|
2023
Q4 | $2.93M | Sell |
|
|||||
|
2023
Q3 | $2.96M | Sell |
|
|||||
|
2023
Q2 | $3.72M | Sell |
|
|||||
|
2023
Q1 | $3.72M | Buy |
|
|||||
|
2022
Q4 | $4.17M | Buy |
|
|||||
|
2022
Q3 | $4.7M | Buy |
|
|||||
|
2022
Q2 | $5.07M | Sell |
|
|||||
|
2022
Q1 | $6.15M | Buy |
|
|||||
|
2021
Q4 | $2.43M | Buy |
|
|||||
|
2021
Q3 | $1.06M | Sell |
|
|||||
|
2021
Q2 | $724K | Buy |
|